New Titles

New Treatises

An error has occurred, which probably means the feed is down. Try again later.

New Answer Books

  • Medical Devices Law and Regulation Answer Book walks you through the current regulatory requirements governing medical devices and describes every aspect from pre-market requirements for specific types of devices to post-market regulation and ongoing government enforcement and investigation. The organization of this text broadly follows the typical life cycle of a device and covers a broad […]
  • Insights from leading experts in medical device law and regulation in a single comprehensive guide to this heavily regulated field. Answers the many common and far-ranging questions that arise when dealing with this complex system of overlapping and competing regulatory requirements.
  • Insights from leading experts in medical device law and regulation in a single comprehensive guide to this heavily regulated field. Answers the many common and far-ranging questions that arise when dealing with this complex system of overlapping and competing regulatory requirements.
  • M&A activity in the health care industry is at its highest level since the 1980s. Health Care Mergers and Acquisitions Answer Book, co-edited by Andrew L. Bab and Kevin A. Rinker at Debevoise & Plimpton LLP, provides the reader with a roadmap to this booming sector. Organized into four parts, it includes practical advice on how […]
  • M&A lawyers health law specialists, and corporate lawyers, —will profit from the insights of experts, distilled into concise questions and answers. Covers industry trends, structuring transactions, due diligence, drafting documents, and health care M&A in selected foreign jurisdictions.

New Course Handbooks

  • At Trial Evidence 2026, participants will learn to apply best practices and analyze strategic considerations for handling evidence at trial, including developing evidentiary issues around artificial intelligence. This program will focus on the Federal Rules of Evidence.
  • At Trial Evidence 2026, participants will learn to apply best practices and analyze strategic considerations for handling evidence at trial, including developing evidentiary issues around artificial intelligence. This program will focus on the Federal Rules of Evidence.
  • Trade secrets can be among an organization’s most valuable assets. Businesses ranging from NASCAR race teams to organizations racing to develop new gene therapies, safer and more reliable autonomous vehicles, more efficient software and new AI platforms and tools depend on trade secrets. Trade secrets law can protect cutting edge technologies, improvements to mature technologies, new […]
  • Trade secrets can be among an organization’s most valuable assets. Businesses ranging from NASCAR race teams to organizations racing to develop new gene therapies, safer and more reliable autonomous vehicles, more efficient software and new AI platforms and tools depend on trade secrets. Trade secrets law can protect cutting edge technologies, improvements to mature technologies, new […]
  • Fund Finance 2026 convenes global industry leaders, finance professionals, and investors to examine the latest trends, strategies, and insights shaping the fund finance market.Now in its seventh year, this premier program will delve into the terms, structures, and intricacies of the market, covering single-fund NAV facilities, secondaries NAV facilities, GP financings, subscription lines, capital call […]